Fabry disease (FD) is an X-linked lysosomal storage disorder, caused by deficient activity of the alpha-galactosidase A enzyme leading to progressive and multisystemic accumulation of globotriaosylceramide. Recent data point toward oxidative stress signalling which could play an important role in both pathophysiology and disease progression.
Id prodotto:
119049
Handle IRIS:
11562/1034974
ultima modifica:
15 novembre 2022
Citazione bibliografica:
Simoncini, C; Torri, S; Montano, V; Chico, L; Gruosso, F; Tuttolomondo, A; Pinto, A; Simonetta, I; Cianci, V; Salviati, A; Vicenzi, V; Marchi, G; Girelli, D; Concolino, D; Sestito, S; Zedde, M; Siciliano, G; Mancuso, Michelangelo,
Oxidative stress biomarkers in Fabry disease: is there a room for them?«Journal of Neurology»
, vol. 267
, n. 12
, 2020
, pp. 3741-3752-3752